These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 1578709

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Treatment of type IIa and type V hyperlipoproteinemia and of a normal volunteer by continuous LDL-apheresis.
    Riesen WF, Sturzenegger E, Imhof C, Descoeudres C, Mordasini R, Oetliker OH.
    Prog Clin Biol Res; 1988; 255():337-46. PubMed ID: 3422496
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of procetofen on apolipoprotein A I and B concentrations in hyperlipoproteinemia.
    Viikari J, Solakivi-Jaakkola T, Lehtonen A.
    Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):362-5. PubMed ID: 6811447
    [Abstract] [Full Text] [Related]

  • 27. Lipoproteins and apolipoproteins. Making use of their metabolic properties to individualize therapy.
    Kottke BA.
    Postgrad Med; 1994 Feb 01; 95(2):51-3, 57-8, 63-5. PubMed ID: 8309863
    [Abstract] [Full Text] [Related]

  • 28. [Determination of LDL and beta-cholesterol in serum. Clinical significance and methodologic possibilities].
    Seidel D, Armstrong V, Cremer P.
    Internist (Berl); 1987 Sep 01; 28(9):606-14. PubMed ID: 3312072
    [No Abstract] [Full Text] [Related]

  • 29. Direct adsorption of lipoproteins (DALI) from whole blood: first long-term clinical experience with a new LDL-apheresis system for the treatment of familial hypercholesterolaemia.
    Jansen M, Banyai S, Schmaldienst S, Goldammer A, Rohac M, Hörl WH, Derfler K.
    Wien Klin Wochenschr; 2000 Jan 28; 112(2):61-9. PubMed ID: 10703153
    [Abstract] [Full Text] [Related]

  • 30. [Effect of diet and drug therapy on the level of high density lipoprotein cholesterol in patients with primary hyperlipoproteinemia].
    Padosh D, Kustosh D, Puchok I, Dem'ianova N, Audikovski M.
    Klin Med (Mosk); 1981 Sep 28; 59(9):45-8. PubMed ID: 7311430
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Lipoprotein metabolism and atherosclerosis--experimental principles].
    Hüttinger M, Dudczak R.
    Vasa Suppl; 1987 Sep 28; 20():52-5. PubMed ID: 3480607
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W, Reuter W.
    Z Gesamte Inn Med; 1982 Dec 15; 37(24):830-3. PubMed ID: 6963524
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Reversible dyslipoproteinemia in patients with malaria is associated with a shortened prostaglandin I2 half-life in plasma.
    Efthimiou Y, Pirich C, Stomatopoulos J, O'Grady J, Sinzinger H.
    Wien Klin Wochenschr; 1992 Dec 15; 104(22):705-6. PubMed ID: 1475977
    [No Abstract] [Full Text] [Related]

  • 38. [Basic principles of drug therapy of hyperlipoproteinemia].
    Romics L.
    Orv Hetil; 1988 Nov 06; 129(45):2391-9. PubMed ID: 3054710
    [No Abstract] [Full Text] [Related]

  • 39. The physical structure of low-density lipoprotein in hyperlipoproteinemias and atherosclerosis.
    Bihari-Varga M, Gruber E, Tölgyesi F.
    Monogr Atheroscler; 1986 Nov 06; 14():173-8. PubMed ID: 3736559
    [No Abstract] [Full Text] [Related]

  • 40. [Clinical risk factors in coronary disease. The Framingham study].
    Castelli WP.
    Wien Med Wochenschr; 1982 Nov 06; 132 Spec No 2():I-IX. PubMed ID: 7168181
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.